Complications

Complication
Timeframe
Likelihood
variable
high

Many of the complications of Takayasu arteritis represent ischemic symptoms related to the development of vascular stenoses and occlusions. Differentiating between ischemia resulting from active vasculitis and ischemia from vascular damage can be difficult. Regular vascular imaging studies can help with follow-up but should also be obtained in the setting of new ischemic symptoms. Attempts to control vascular inflammation are needed to try to minimize long-term vascular damage.

variable
high

Hypertension is a common complication, usually due to renal artery or aortic valve stenosis.[8]

variable
high

Long-term glucocorticoid therapy increases the risk of osteoporosis, and the greatest amount of bone loss occurs in the first 6 to 12 months of therapy. Risk is proportional to cumulative dose, so glucocorticoid dose should be reduced as soon as possible.

variable
medium

Long-term glucocorticoid therapy can cause the development of diabetes mellitus. A high degree of vigilance is required.

variable
medium

Patients require influenza and pneumococcal immunizations annually. Use of prophylactic antibiotic therapy to prevent Pneumocystis jirovecii pneumonia is important, especially when the prednisone dose is more than 20 mg daily.

variable
medium

Most often involves the ascending thoracic aorta.

variable
medium

Aortic valve insufficiency, usually due to aortic root dilation, is found in about 25% of patients.[8]​ Echocardiography may be helpful to evaluate aortic valve function in patients with confirmed proximal aortic arteritis.[26]

variable
medium

Congestive heart failure occurs in about 25% of patients.[8]

variable
low

Angina from coronary artery involvement is described in up to 10% of patients.[8]

variable
low

Involvement of carotid or vertebral arteries can result in a transient ischemic attack or stroke. Visual disturbance including blurred vision and amaurosis fugax may be present, but permanent visual loss is uncommon.[8]

Use of this content is subject to our disclaimer